Dirk Roos
- Immunology top 0.05%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 173
- Immune Response and Inflammation 63
- Immunodeficiency and Autoimmune Disorders 30
- Immunology and Allergy top 0.05%
- Cell Adhesion Molecules Research 68
- Hematology top 0.2%
- Platelet Disorders and Treatments 29
- Physiology top 0.2%
- Physiology top 0.5%
-
- Blood disorders and treatments 63
-
- Monoclonal and Polyclonal Antibodies Research 34
-
- S100 Proteins and Annexins 31
Dirk Roos
421 papers receiving 23.9k citations
Hit Papers
Peers
Comparison fields: 5 of 162
- Immunology 13.2k
- Immunology and Allergy 3.1k
- Hematology 2.2k
- Physiology 3.8k
- Physiology 534
Countries citing papers authored by Dirk Roos
This map shows the geographic impact of Dirk Roos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Roos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Roos more than expected).
Fields of papers citing papers by Dirk Roos
This network shows the impact of papers produced by Dirk Roos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Roos. The network helps show where Dirk Roos may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dirk Roos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 10 | |
| 2 | 2015 | 134 | |
| 3 | 2013 | 205 | |
| 4 | SIRP alpha controls phagocyte NADPH oxidase function by limiting the expression of gp91(phox) | 2010 | 1 |
| 5 | 2009 | 124 | |
| 6 | 2009 | 29 | |
| 7 | 2008 | 160 | |
| 8 | 2008 | 83 | |
| 9 | 2008 | 76 | |
| 10 | 2008 | 191 | |
| 11 | 2006 | 76 | |
| 12 | The search for a genetic defect in Polish patients with chronic granulomatous disease. | 2005 | 4 |
| 13 | 2004 | 73 | |
| 14 | 2003 | 37 | |
| 15 | 2002 | 81 | |
| 16 | 2001 | 56 | |
| 17 | 2000 | 81 | |
| 18 | 1999 | 27 | |
| 19 | 1993 | 16 | |
| 20 | Familial deficiency of granulocyte bactericidal capacity associated with growth retardation. | 1978 | 3 |
About Dirk Roos
Dirk Roos is a scholar working on Immunology and Allergy, Immunology and Hematology, having authored 427 papers that have together received 24.9k indexed citations. Recurring topics across this work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (173 papers), Cell Adhesion Molecules Research (68 papers), Blood disorders and treatments (63 papers), Immune Response and Inflammation (63 papers), Monoclonal and Polyclonal Antibodies Research (34 papers), S100 Proteins and Annexins (31 papers), Immunodeficiency and Autoimmune Disorders (30 papers) and Platelet Disorders and Treatments (29 papers). The work is most often cited by research in Immunology (13.2k citations), Immunology and Allergy (3.1k citations) and Hematology (2.2k citations). Dirk Roos has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Taco W. Kuijpers, Martin de Boer, Masja de Haas, J.A. Loos, AJ Verhoeven, Marion Kleijer, Weening Rs, Ron S. Weening, Erik Mul and Rob van Zwieten. Their work appears in journals such as Blood, The Journal of Immunology, Journal of Clinical Investigation, Journal of Biological Chemistry and Clinical & Experimental Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.